A
A. Marc Gillinov
Researcher at Cleveland Clinic
Publications - 389
Citations - 27670
A. Marc Gillinov is an academic researcher from Cleveland Clinic. The author has contributed to research in topics: Mitral valve & Mitral valve repair. The author has an hindex of 77, co-authored 362 publications receiving 25025 citations. Previous affiliations of A. Marc Gillinov include University of Cincinnati & Kent State University.
Papers
More filters
Journal ArticleDOI
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons
Andrew E. Epstein,John P. DiMarco,Kenneth A. Ellenbogen,N.A. Mark Estes,Roger A. Freedman,Leonard S. Gettes,A. Marc Gillinov,Gabriel Gregoratos,Stephen C. Hammill,David L. Hayes,Mark A. Hlatky,L. Kristin Newby,Richard L. Page,Mark H. Schoenfeld,Michael J. Silka,Lynne W. Stevenson,Michael O. Sweeney +16 more
TL;DR: Sidney C. Smith, Jr,MD, FACC, FAHA, Chair Alice K. Jacobs, MD, F ACC,FAHA, Vice-Chair Cynthia D. Adams, RN, PhD, FAH.
Journal ArticleDOI
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
Andrew E. Epstein,John P. DiMarco,Kenneth A. Ellenbogen,N.A. Mark Estes,Roger A. Freedman,Leonard S. Gettes,A. Marc Gillinov,Gabriel Gregoratos,Stephen C. Hammill,David L. Hayes,Mark A. Hlatky,L. Kristin Newby,Richard L. Page,Mark H. Schoenfeld,Michael J. Silka,Lynne W. Stevenson,Michael O. Sweeney +16 more
Journal ArticleDOI
ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities.
Andrew E. Epstein,John P. DiMarco,Kenneth A. Ellenbogen,N.A. Mark Estes,Roger A. Freedman,Leonard S. Gettes,A. Marc Gillinov,Gabriel Gregoratos,Stephen C. Hammill,David L. Hayes,Mark A. Hlatky,L. Kristin Newby,Richard L. Page,Mark H. Schoenfeld,Michael J. Silka,Lynne W. Stevenson,Michael O. Sweeney,Sidney C. Smith,Alice K. Jacobs,Cynthia D. Adams,Jeffrey L. Anderson,Christopher E. Buller,Mark A. Creager,Steven M. Ettinger,David P. Faxon,Jonathan L. Halperin,Loren F. Hiratzka,Sharon A. Hunt,Harlan M. Krumholz,Frederick G. Kushner,Bruce W. Lytle,Rick A. Nishimura,Joseph P. Ornato,Barbara Riegel,Lynn G. Tarkington,Clyde W. Yancy +35 more
TL;DR: The American College of Cardiology Foundation Board of Trustees in February 2008, document be cited as follows.
Journal ArticleDOI
Two-year outcomes of surgical treatment of severe ischemic mitral regurgitation
Robert E. Michler,Peter K. Smith,Michael K. Parides,Gorav Ailawadi,Vinod H. Thourani,Alan J. Moskowitz,Michael A. Acker,Judy Hung,Helena L. Chang,Louis P. Perrault,A. Marc Gillinov,Michael Argenziano,Emilia Bagiella,Jessica Overbey,Ellen Moquete,Lopa N. Gupta,Marissa A. Miller,Wendy C. Taddei-Peters,Neal Jeffries,Richard D. Weisel,Eric A. Rose,James S. Gammie,James S. Gammie,Joseph J. DeRose,John D. Puskas,François Dagenais,Sandra G. Burks,Ismail El-Hamamsy,Carmelo A. Milano,Pavan Atluri,Pierre Voisine,Patrick T. O'Gara,Annetine C. Gelijns +32 more
TL;DR: Mitral-valve repair provided a more durable correction of mitral regurgitation but did not significantly improve survival or reduce overall adverse events or readmissions and was associated with an early hazard of increased neurologic events and supraventricular arrhythmias.
Journal ArticleDOI
Recurrent mitral regurgitation after annuloplasty for functional ischemic mitral regurgitation
Edwin C. McGee,A. Marc Gillinov,Eugene H. Blackstone,Jeevanantham Rajeswaran,Gideon Cohen,Farzad Najam,Takahiro Shiota,Joseph F. Sabik,Bruce W. Lytle,Patrick M. McCarthy,Delos M. Cosgrove +10 more
TL;DR: Although initial mitral valve replacement would eliminate the risk of postoperative mitral regurgitation, this strategy has been associated with reduced survival, and the development of additional techniques is necessary to achieve more secure repair of functional ischemic mitral Regurgitation.